ATE141649T1 - Verfahren zum nachweis von hydrolytischen enzymen - Google Patents

Verfahren zum nachweis von hydrolytischen enzymen

Info

Publication number
ATE141649T1
ATE141649T1 AT92305109T AT92305109T ATE141649T1 AT E141649 T1 ATE141649 T1 AT E141649T1 AT 92305109 T AT92305109 T AT 92305109T AT 92305109 T AT92305109 T AT 92305109T AT E141649 T1 ATE141649 T1 AT E141649T1
Authority
AT
Austria
Prior art keywords
resin
binding
assay method
scissile bond
plates
Prior art date
Application number
AT92305109T
Other languages
English (en)
Inventor
William Francis Heath Jr
Mei-Huei Tsai Lai
Joseph Vincent Manetta
John Richard Sportsman
Sau-Chi Betty Yan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE141649T1 publication Critical patent/ATE141649T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
AT92305109T 1991-06-10 1992-06-03 Verfahren zum nachweis von hydrolytischen enzymen ATE141649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/712,828 US5235039A (en) 1991-06-10 1991-06-10 Substrates for hiv protease

Publications (1)

Publication Number Publication Date
ATE141649T1 true ATE141649T1 (de) 1996-09-15

Family

ID=24863712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92305109T ATE141649T1 (de) 1991-06-10 1992-06-03 Verfahren zum nachweis von hydrolytischen enzymen

Country Status (7)

Country Link
US (1) US5235039A (de)
EP (1) EP0518557B1 (de)
JP (1) JPH05194591A (de)
AT (1) ATE141649T1 (de)
CA (1) CA2070719A1 (de)
DE (1) DE69212911D1 (de)
DK (1) DK0518557T3 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
BR9306058A (pt) * 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
DE4217474A1 (de) * 1992-05-27 1993-12-02 Boehringer Mannheim Gmbh Verfahren und Mittel zur Bestimmung eines Analyts
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5846993A (en) * 1992-12-22 1998-12-08 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US6348310B1 (en) * 1994-03-04 2002-02-19 Promega Corporation Quantitation of individual protein kinase activity
WO1995026505A1 (en) * 1994-03-29 1995-10-05 Gruppo Lepetit S.P.A. Solid phase immunoassay to detect inhibitors of proteolytic enzymes
US5527829A (en) * 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
CA2201616A1 (en) * 1994-10-07 1996-04-18 Vincent A. Fischetti Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
DE69527405T2 (de) * 1994-10-19 2003-03-13 Novartis Ag, Basel Antivirale Ether von Aspartat-Protease-Substrat-Isosteren
WO1997025437A1 (en) * 1996-01-04 1997-07-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for assaying proteolytic enzymes using fluorescence-quenched substrates
EP0909322B1 (de) 1996-04-30 2005-11-16 Twinstrand Therapeutics Inc. Antivirale variante von ricin-proteinen
US5925759A (en) 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US5962725A (en) 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
KR100487715B1 (ko) * 1997-05-01 2005-05-09 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 염료 이합체화에 기초한 형광발생 프로테아제 기질
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US6908770B1 (en) 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
US6312896B1 (en) * 1998-09-17 2001-11-06 Igen Inaternational, Inc. Assays for measuring nucleic acid binding proteins and enzyme activities
FR2786789B1 (fr) * 1998-12-08 2001-12-28 Proteus Methode de detection in vitro d'une sequence d'acide nucleique cible dans un echantillon d'acide nucleique
FR2786788B1 (fr) * 1998-12-08 2002-04-19 Proteus Procede de criblage de substances capables de modifier l'activite d'une ou plusieurs proteines cibles ou d'un ensemble cible de proteines exprimees in vitro
FR2786787B1 (fr) * 1998-12-08 2002-04-19 Proteus Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
US6911307B1 (en) 1998-12-08 2005-06-28 Proteus S.A. Method of detection in vitro of a target substance in a sample comprising the labelling of said substance with a reporter gene and with the sequences necessary for the expression of said reporter gene in vitro
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins
CA2270639A1 (en) * 1999-05-10 2000-11-10 Zhibo Gan A method for measuring biomolecules
MXPA01012270A (es) 1999-05-28 2003-06-24 Virco Nv Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
ATE497164T1 (de) * 1999-06-09 2011-02-15 Molecular Devices Inc Testverfahren zur messung der phosphorylierung
US6602702B1 (en) * 1999-07-16 2003-08-05 The University Of Texas System Detection system based on an analyte reactive particle
US7022517B1 (en) 1999-07-16 2006-04-04 Board Of Regents, The University Of Texas System Method and apparatus for the delivery of samples to a chemical sensor array
GB9929674D0 (en) 1999-12-15 2000-02-09 Novartis Res Found Protease-activated receptor (PAR) modulator assays
AU2001247195A1 (en) 2000-01-31 2001-08-07 Board Of Regents, The University Of Texas System Method and system for collecting and transmitting chemical information
AU2002226316B2 (en) 2000-10-20 2008-06-26 Virco Bvba Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
US6818396B1 (en) 2000-11-28 2004-11-16 Proteus S.A. Process for determination of the activity of a substance using an in vitro functional test
EP1451348B1 (de) * 2001-09-10 2015-08-12 Meso Scale Technologies, LLC Verfahren, reagentien, kits und vorrichtungen zur proteinfunktionsanalyse
US7320878B2 (en) 2001-11-08 2008-01-22 Tibotec Pharmaceuticals, Ltd. Protease assay for therapeutic drug monitoring
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
CN100525829C (zh) * 2002-04-15 2009-08-12 美国国家红十字会 检测混合物中配体和靶标的方法
WO2003090605A2 (en) 2002-04-26 2003-11-06 Board Of Regents, The University Of Texas System Method and system for the detection of cardiac risk factors
CA2490764C (en) 2002-07-01 2011-11-22 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1520247B1 (de) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutationsprofile bei mit phänotypischer medikamentenresistenz korrelierter hiv-1-protease
CA2549190A1 (en) 2003-12-11 2005-06-30 Board Of Regents, The University Of Texas System Method and system for the analysis of saliva using a sensor array
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
US8105849B2 (en) 2004-02-27 2012-01-31 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements
US7781226B2 (en) 2004-02-27 2010-08-24 The Board Of Regents Of The University Of Texas System Particle on membrane assay system
EP1910824A4 (de) 2005-05-31 2012-11-21 Labnow Inc Verfahren und zusammensetzungen in zusammenhang mit der erstellung und verwendung eines weissen blutbildes
CN105136699B (zh) * 2015-08-25 2018-03-16 四川大学 基于未变性染色皮粉底物的蛋白酶胶原蛋白水解活力测定方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563827B2 (en) * 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4569907A (en) * 1984-01-16 1986-02-11 Monsanto Company Thiopeptolide substrates for vertebrate collagenase
DE3531778A1 (de) * 1985-09-06 1987-03-12 Behringwerke Ag Verfahren zur bestimmung von proteaseinhibitoren
CA1333883C (en) * 1988-04-07 1995-01-10 Shashidhara H. M. Murthy Immunoassay utilizing biotin bridge with universal solid phase
DE3842197A1 (de) * 1988-12-15 1990-06-21 Hoechst Ag Rasch spaltbares substrat fuer die hiv-protease

Also Published As

Publication number Publication date
EP0518557B1 (de) 1996-08-21
US5235039A (en) 1993-08-10
DK0518557T3 (da) 1996-09-09
JPH05194591A (ja) 1993-08-03
DE69212911D1 (de) 1996-09-26
EP0518557A3 (en) 1993-06-16
EP0518557A2 (de) 1992-12-16
CA2070719A1 (en) 1992-12-11

Similar Documents

Publication Publication Date Title
DE69212911D1 (de) Verfahren zum Nachweis von hydrolytischen Enzymen
US6243980B1 (en) Protease inhibitor assay
ATE116334T1 (de) Reagens und methode zum nachweis der wirksamkeit von retroviraler protease.
FI91193B (fi) Menetelmä nesteessä olevan ligandin detektoimiseksi ja menetelmässä käyttökelpoinen välineistö
DE69031665D1 (de) Nachweis von Nukleinsäuresequenzen unter Verwendung von Fluoreszenz-Polarisation
ATE335836T1 (de) Verfahren und kit zum nachweis von betalactam enthaltenden verbindungen
DE60001406D1 (de) Apparat und methode zur präzisen lokalisierung von reaktionsplatten
DE602004026888D1 (de) Kinase- und phosphatasetests
ATE336721T1 (de) Hoch-durchsatz assay zur messung von zellulären antworten mit hilfe von mikroarrays
Johansen et al. Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis
DE69836275D1 (de) Zellkulturmedien zum spezifischen nachweis von verschiedenen candida-spezies, sowie testmethoden
WO2003035896A3 (en) Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity
ATE200108T1 (de) Verfahren zum nachweis von telomerase-aktivität
CA2064793A1 (en) Hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
WO2001061031A3 (en) Improved assay for protein tyrosine phosphatases
DE69813850D1 (de) Homogene nachweisverfahren zur bestimmung der phosphorylierungsaktivitäten von biologischem material
ATE78517T1 (de) Polarisierter fluoreszenztest von makromolekularen hydrolasen.
DE60314395D1 (de) Verfahren zum messen von protein kinase und phosphatase aktivität
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
JP2009106294A (ja) トランスフェラーゼのための方法およびキット
ATE359513T1 (de) Hochdurchsatzscreening von verbindungen für biologische wirksamkeit
DE69837399D1 (de) Verfahren zum screening von tgf-beta inhibierenden substanzen
RU2005116827A (ru) Способы и композиции для определения характеристик фермента окислительно-восстановительной системы реагентов
Marguerre et al. Lanthanide-based fluorogenic peptide substrate for the highly sensitive detection of thermolysin
MY104675A (en) Chromogenic substrate for esterase and immunoassay using same.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties